Crysvita Indications/Uses

burosumab

Manufacturer:

Kyowa Kirin

Distributor:

Zuellig Pharma

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Indications/Uses

CRYSVITA is indicated for the treatment of X-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in